Delta opioid receptors mediate chemotaxis in bone marrow-derived dendritic cells
- PMID: 18486241
- DOI: 10.1016/j.jneuroim.2008.03.020
Delta opioid receptors mediate chemotaxis in bone marrow-derived dendritic cells
Abstract
Endogenous opioid peptides are locally produced at the inflammatory site where antigens are captured and processed by dendritic cells (DCs). Subsequently, maturing DCs migrate towards draining lymph nodes to initiate T cell response. Given the primordial role of DCs in adaptive immune response, we examined whether opioids may affect the migratory response of DCs. We found that the delta opioid receptor (DOR) mRNA was expressed at low level in bone marrow-derived immature DCs and up-regulated upon DC maturation. Moreover, DOR agonists triggered DC chemotaxis in vitro. In vivo, enkephalins prevented the egress of mature DCs injected into the peritoneal cavity of normal mice. This effect was inhibited by blocking opioid receptors on mature DCs. The cross-talk between CCR7 and DOR receptors that are both up-regulated during DC maturation was then examined. Whereas opioids did not alter the migratory responsiveness to CCR7 ligands, DOR-mediated mobilization of mature DCs was inhibited by CCL19 and CCL21 suggesting that the opioid chemotactic activity decreases as the concentration of the chemokines increases.
Similar articles
-
EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation.J Immunol. 1998 Sep 15;161(6):3096-102. J Immunol. 1998. PMID: 9743376
-
CCR7-mediated c-Jun N-terminal kinase activation regulates cell migration in mature dendritic cells.Int Immunol. 2005 Sep;17(9):1201-12. doi: 10.1093/intimm/dxh297. Epub 2005 Jul 18. Int Immunol. 2005. PMID: 16027136
-
CCL21 is sufficient to mediate DC migration, maturation and function in the absence of CCL19.Eur J Immunol. 2010 May;40(5):1266-71. doi: 10.1002/eji.200939921. Eur J Immunol. 2010. PMID: 20201039
-
A myriad of functions and complex regulation of the CCR7/CCL19/CCL21 chemokine axis in the adaptive immune system.Cytokine Growth Factor Rev. 2013 Jun;24(3):269-83. doi: 10.1016/j.cytogfr.2013.03.001. Epub 2013 Apr 12. Cytokine Growth Factor Rev. 2013. PMID: 23587803 Review.
-
The multiple personalities of the chemokine receptor CCR7 in dendritic cells.J Immunol. 2006 May 1;176(9):5153-9. doi: 10.4049/jimmunol.176.9.5153. J Immunol. 2006. PMID: 16621978 Review.
Cited by
-
Recent advances on the δ opioid receptor: from trafficking to function.Br J Pharmacol. 2015 Jan;172(2):403-19. doi: 10.1111/bph.12706. Epub 2014 Jul 1. Br J Pharmacol. 2015. PMID: 24665909 Free PMC article. Review.
-
Autoantibodies to the delta-opioid receptor function as opioid agonists and display immunomodulatory activity.J Neuroimmunol. 2009 Dec 10;217(1-2):65-73. doi: 10.1016/j.jneuroim.2009.10.007. Epub 2009 Oct 30. J Neuroimmunol. 2009. PMID: 19879656 Free PMC article.
-
Endogenous analgesia mediated by CD4(+) T lymphocytes is dependent on enkephalins in mice.J Neuroinflammation. 2016 Jun 1;13(1):132. doi: 10.1186/s12974-016-0591-x. J Neuroinflammation. 2016. PMID: 27245576 Free PMC article.
-
The novel mechanism of anticancer effect on gastric cancer through inducing G0/G1 cell cycle arrest and caspase-dependent apoptosis in vitro and in vivo by methionine enkephalin.Cancer Manag Res. 2018 Oct 18;10:4773-4787. doi: 10.2147/CMAR.S178343. eCollection 2018. Cancer Manag Res. 2018. PMID: 30425572 Free PMC article.
-
Multi-chemokine receptor antagonist RAP-103 inhibits opioid-derived respiratory depression, reduces opioid reinforcement and physical dependence, and normalizes opioid-induced dysregulation of mesolimbic chemokine receptors in rats.Drug Alcohol Depend. 2022 Sep 1;238:109556. doi: 10.1016/j.drugalcdep.2022.109556. Epub 2022 Jul 11. Drug Alcohol Depend. 2022. PMID: 35843139 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources